Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma.

Nathan V, Johansson PA, Palmer JM, Howlie M, Hamilton HR, Wadt K, Jönsson G, Brooks KM, Pritchard AL, Hayward NK.

Pigment Cell Melanoma Res. 2019 Jun 24. doi: 10.1111/pcmr.12804. [Epub ahead of print]

PMID:
31233279
2.

Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarate.

Brooks KM, Ibrahim ME, Castillo-Mancilla JR, MaWhinney S, Alexander K, Tilden S, Kerr BJ, Ellison L, McHugh C, Bushman LR, Kiser JJ, Hosek S, Huhn GD, Anderson PL.

J Antimicrob Chemother. 2019 May 15. pii: dkz187. doi: 10.1093/jac/dkz187. [Epub ahead of print]

PMID:
31093649
3.

Increased tenofovir monoester concentrations in patients receiving tenofovir disoproxil fumarate with ledipasvir/sofosbuvir.

Brooks KM, Castillo-Mancilla JR, Blum J, Huntley R, MaWhinney S, Alexander K, Kerr BJ, Ellison L, Bushman LR, MacBrayne CE, Anderson PL, Kiser JJ.

J Antimicrob Chemother. 2019 May 12. pii: dkz184. doi: 10.1093/jac/dkz184. [Epub ahead of print]

PMID:
31081036
4.

Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?

Brooks KM, Sherman EM, Egelund EF, Brotherton A, Durham S, Badowski ME, Cluck DB.

Pharmacotherapy. 2019 May;39(5):576-598. doi: 10.1002/phar.2246. Epub 2019 Apr 1. Review.

PMID:
30860610
5.

Pharmacologic-Based Methods of Adherence Assessment in HIV Prevention.

Brooks KM, Anderson PL.

Clin Pharmacol Ther. 2018 Dec;104(6):1056-1059. doi: 10.1002/cpt.1201. Epub 2018 Sep 4. No abstract available.

PMID:
30178462
6.
7.

Short Communication: Bioequivalence of Tenofovir and Emtricitabine After Coencapsulation with the Proteus Ingestible Sensor.

Ibrahim ME, Brooks KM, Castillo-Mancilla JR, McHugh C, Morrow M, Brothers J, MaWhinney S, Hosek S, Huhn G, Anderson PL.

AIDS Res Hum Retroviruses. 2018 Oct;34(10):835-837. doi: 10.1089/AID.2018.0081. Epub 2018 Sep 5.

PMID:
30047286
8.

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.

Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, de Jesus AA, Chapelle DC, Kim H, Dill S, Colbert RA, Failla L, Kost B, O'Brien M, Reynolds JC, Folio LR, Calvo KR, Paul SM, Weir N, Brofferio A, Soldatos A, Biancotto A, Cowen EW, Digiovanna JJ, Gadina M, Lipton AJ, Hadigan C, Holland SM, Fontana J, Alawad AS, Brown RJ, Rother KI, Heller T, Brooks KM, Kumar P, Brooks SR, Waldman M, Singh HK, Nickeleit V, Silk M, Prakash A, Janes JM, Ozen S, Wakim PG, Brogan PA, Macias WL, Goldbach-Mansky R.

J Clin Invest. 2018 Jul 2;128(7):3041-3052. doi: 10.1172/JCI98814. Epub 2018 Jun 11.

9.

Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine.

Brooks KM, George JM, Pau AK, Rupert A, Mehaffy C, De P, Dobos KM, Kellogg A, McLaughlin M, McManus M, Alfaro RM, Hadigan C, Kovacs JA, Kumar P.

Clin Infect Dis. 2018 Jul 2;67(2):193-201. doi: 10.1093/cid/ciy082.

10.

Alterations in Hydrocortisone Pharmacokinetics in a Patient With Congenital Adrenal Hyperplasia Following Bariatric Surgery.

Mallappa A, Nella AA, Kumar P, Brooks KM, Perritt AF, Ling A, Liu CY, Merke DP.

J Endocr Soc. 2017 Jun 21;1(7):994-1001. doi: 10.1210/js.2017-00215. eCollection 2017 Jul 1.

11.

Test Dose Pharmacokinetics in Pediatric Patients Receiving Once-Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach?

Brooks KM, Jarosinski P, Hughes T, Kang E, Shah NN, Gall JBL, Hickstein DD, De Ravin SS, George JM, Kumar P.

J Clin Pharmacol. 2018 Mar;58(3):332-339. doi: 10.1002/jcph.1049. Epub 2017 Dec 14.

12.

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

Zimmerman O, Rösler B, Zerbe CS, Rosen LB, Hsu AP, Uzel G, Freeman AF, Sampaio EP, Rosenzweig SD, Kuehn HS, Kim T, Brooks KM, Kumar P, Wang X, Netea MG, van de Veerdonk FL, Holland SM.

Open Forum Infect Dis. 2017 Sep 22;4(4):ofx202. doi: 10.1093/ofid/ofx202. eCollection 2017 Fall.

13.

Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI Patients.

Kim H, Brooks KM, Tang CC, Wakim P, Blake M, Brooks SR, Montealegre Sanchez GA, de Jesus AA, Huang Y, Tsai WL, Gadina M, Prakash A, Janes JM, Zhang X, Macias WL, Kumar P, Goldbach-Mansky R.

Clin Pharmacol Ther. 2018 Aug;104(2):364-373. doi: 10.1002/cpt.936. Epub 2017 Dec 8.

PMID:
29134648
14.

Safety, tolerability, and pharmacokinetics of radavirsen (AVI-7100), an antisense oligonucleotide targeting influenza a M1/M2 translation.

Beigel JH, Voell J, Muñoz P, Kumar P, Brooks KM, Zhang J, Iversen P, Heald A, Wong M, Davey RT.

Br J Clin Pharmacol. 2018 Jan;84(1):25-34. doi: 10.1111/bcp.13405. Epub 2017 Sep 22.

15.

The role of jab1, a putative downstream effector of the neurotrophic cytokine macrophage migration inhibitory factor (MIF) in zebrafish inner ear hair cell development.

Weber LJ, Marcy HK, Shen YC, Tomkovich SE, Brooks KM, Hilk KE, Barald KF.

Exp Neurol. 2018 Mar;301(Pt B):100-109. doi: 10.1016/j.expneurol.2017.09.009. Epub 2017 Sep 18.

PMID:
28928022
16.

Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran.

Kumar P, Gordon LA, Brooks KM, George JM, Kellogg A, McManus M, Alfaro RM, Nghiem K, Lozier J, Hadigan C, Penzak SR.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01201-17. doi: 10.1128/AAC.01201-17. Print 2017 Nov.

17.

Brief report: Laboratory characterization of noroviruses identified in specimens from Military Health System beneficiaries during an outbreak in Germany, 2016-2017.

Darling ND, Poss DE, Brooks KM, Steele JA, Allen KC, Graf PC, Coldren RL, Pederson DB, Kayatani AK, Harris S.

MSMR. 2017 Jul;24(7):26-29. No abstract available.

PMID:
28731728
18.

Decreased Absorption of Dolutegravir and Tenofovir Disoproxil Fumarate, But Not Emtricitabine, in an HIV-Infected Patient Following Oral and Jejunostomy-Tube Administration.

Brooks KM, Garrett KL, Kuriakose SS, George JM, Balba G, Bailey B, Anderson M, Lane HC, Maldarelli F, Pau AK.

Pharmacotherapy. 2017 Aug;37(8):e82-e89. doi: 10.1002/phar.1960. Epub 2017 Jul 18.

19.

Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers.

Gordon LA, Kumar P, Brooks KM, Kellogg A, McManus M, Alfaro RM, Nghiem K, George JM, Lozier J, Penzak SR, Hadigan C.

Circulation. 2016 Dec 6;134(23):1909-1911. No abstract available.

20.

Drug interactions in HIV treatment: complementary & alternative medicines and over-the-counter products.

Brooks KM, George JM, Kumar P.

Expert Rev Clin Pharmacol. 2017 Jan;10(1):59-79. doi: 10.1080/17512433.2017.1246180. Epub 2016 Oct 24. Review.

PMID:
27715369
21.

Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer.

Giovinazzo H, Kumar P, Sheikh A, Brooks KM, Ivanovic M, Walsh M, Caron WP, Kowalsky RJ, Song G, Whitlow A, Clarke-Pearson DL, Brewster WR, Van Le L, Zamboni BA, Bae-Jump V, Gehrig PA, Zamboni WC.

Cancer Chemother Pharmacol. 2016 Mar;77(3):565-73. doi: 10.1007/s00280-015-2945-y. Epub 2016 Jan 28.

PMID:
26822231
22.

National Institutes of Health Perspective on Reports of Gadolinium Deposition in the Brain.

Malayeri AA, Brooks KM, Bryant LH, Evers R, Kumar P, Reich DS, Bluemke DA.

J Am Coll Radiol. 2016 Mar;13(3):237-41. doi: 10.1016/j.jacr.2015.11.009. Epub 2016 Jan 23. Review. No abstract available.

23.

Shortfalls of the use of HbA1C-derived eAG in older adults with diabetes.

Munshi MN, Segal AR, Slyne C, Samur AA, Brooks KM, Horton ES.

Diabetes Res Clin Pract. 2015 Oct;110(1):60-65. doi: 10.1016/j.diabres.2015.07.012. Epub 2015 Aug 3.

PMID:
26272739
24.

A Role for Low Density Lipoprotein Receptor-Related Protein 1 in the Cellular Uptake of Tissue Plasminogen Activator in the Lungs.

Lin S, Racz J, Tai MF, Brooks KM, Rzeczycki P, Heath LJ, Newstead MW, Standiford TJ, Rosania GR, Stringer KA.

Pharm Res. 2016 Jan;33(1):72-82. doi: 10.1007/s11095-015-1763-6. Epub 2015 Aug 1.

25.

Gardnerella vaginalis triggers NLRP3 inflammasome recruitment in THP-1 monocytes.

Vick EJ, Park HS, Huff KA, Brooks KM, Farone AL, Farone MB.

J Reprod Immunol. 2014 Dec;106:67-75. doi: 10.1016/j.jri.2014.08.005. Epub 2014 Sep 16.

PMID:
25280956
26.

Barriers and facilitators to self-care communication during medical appointments in the United States for adults with type 2 diabetes.

Ritholz MD, Beverly EA, Brooks KM, Abrahamson MJ, Weinger K.

Chronic Illn. 2014 Dec;10(4):303-13. doi: 10.1177/1742395314525647. Epub 2014 Feb 24.

27.

Impact of reinforcement of diabetes self-care on poorly controlled diabetes: a randomized controlled trial.

Beverly EA, Fitzgerald SM, Brooks KM, Hultgren BA, Ganda OP, Munshi M, Weinger K.

Diabetes Educ. 2013 Jul-Aug;39(4):504-14. doi: 10.1177/0145721713486837. Epub 2013 May 2.

28.

Assessment of emotional struggles in type 2 diabetes: patient perspectives.

Beverly EA, Brooks KM, Ritholz MD, Abrahamson MJ, Weinger K.

Diabetes Care. 2012 Aug;35(8):e62. doi: 10.2337/dc12-0661. No abstract available.

29.

Look who's (not) talking: diabetic patients' willingness to discuss self-care with physicians.

Beverly EA, Ganda OP, Ritholz MD, Lee Y, Brooks KM, Lewis-Schroeder NF, Hirose M, Weinger K.

Diabetes Care. 2012 Jul;35(7):1466-72. doi: 10.2337/dc11-2422. Epub 2012 May 22.

30.

A qualitative study of perceived responsibility and self-blame in type 2 diabetes: reflections of physicians and patients.

Beverly EA, Ritholz MD, Brooks KM, Hultgren BA, Lee Y, Abrahamson MJ, Weinger K.

J Gen Intern Med. 2012 Sep;27(9):1180-7. doi: 10.1007/s11606-012-2070-0. Epub 2012 May 2.

31.

Physicians' perceptions of the type 2 diabetes multi-disciplinary treatment team: a qualitative study.

Ritholz MD, Beverly EA, Abrahamson MJ, Brooks KM, Hultgren BA, Weinger K.

Diabetes Educ. 2011 Nov-Dec;37(6):794-800. doi: 10.1177/0145721711423320. Epub 2011 Oct 14.

32.

Drosophila male courtship behavior is modulated by ecdysteroids.

Ganter GK, Panaitiu AE, Desilets JB, Davis-Heim JA, Fisher EA, Tan LC, Heinrich R, Buchanan EB, Brooks KM, Kenney MT, Verde MG, Downey J, Adams AM, Grenier JS, Maddula S, Shah P, Kincaid KM, O'Brien JR.

J Insect Physiol. 2011 Sep;57(9):1179-84. doi: 10.1016/j.jinsphys.2011.05.007. Epub 2011 Jun 15.

33.

Understanding physicians' challenges when treating type 2 diabetic patients' social and emotional difficulties: a qualitative study.

Beverly EA, Hultgren BA, Brooks KM, Ritholz MD, Abrahamson MJ, Weinger K.

Diabetes Care. 2011 May;34(5):1086-8. doi: 10.2337/dc10-2298. Epub 2011 Mar 16.

34.

Rapid steps in the glmS ribozyme catalytic pathway: cation and ligand requirements.

Brooks KM, Hampel KJ.

Biochemistry. 2011 Apr 5;50(13):2424-33. doi: 10.1021/bi101842u. Epub 2011 Mar 11.

35.

A rate-limiting conformational step in the catalytic pathway of the glmS ribozyme.

Brooks KM, Hampel KJ.

Biochemistry. 2009 Jun 23;48(24):5669-78. doi: 10.1021/bi900183r.

PMID:
19449899
36.

Inhibitors of cellular signalling are cytotoxic or block the budded-to-hyphal transition in the pathogenic yeast Candida albicans.

Toenjes KA, Stark BC, Brooks KM, Johnson DI.

J Med Microbiol. 2009 Jun;58(Pt 6):779-90. doi: 10.1099/jmm.0.006841-0.

37.

Considerations in developing an integrated pest management programme for control of sea lice on farmed salmon in Pacific Canada.

Brooks KM.

J Fish Dis. 2009 Jan;32(1):59-73. doi: 10.1111/j.1365-2761.2008.01013.x.

PMID:
19245631
38.

Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia.

Smart CE, Clarke C, Brooks KM, Raghavendra A, Brewster BL, French JD, Hetherington R, Fleming JS, Rothnagel JA, Wainwright B, Lakhani SR, Brown MA.

Breast Cancer Res Treat. 2008 Nov;112(2):237-41. Epub 2007 Dec 20.

PMID:
18095153
39.

Increased male-male courtship in ecdysone receptor deficient adult flies.

Ganter GK, Walton KL, Merriman JO, Salmon MV, Brooks KM, Maddula S, Kravitz EA.

Behav Genet. 2007 May;37(3):507-12. Epub 2007 Jan 20.

PMID:
17238001
40.

Synthesis and structure-activity relationship of the isoindolinyl benzisoxazolpiperidines as potent, selective, and orally active human dopamine D4 receptor antagonists.

Hendrix JA, Shimshock SJ, Shutske GM, Tomer JD 4th, Kapples KJ, Palermo MG, Corbett TJ, Vargas HM, Kafka S, Brooks KM, Laws-Ricker L, Lee DK, de Lannoy I, Bordeleau M, Rizkalla G, Owolabi J, Kamboj RK.

Chembiochem. 2002 Oct 4;3(10):999-1009.

PMID:
12362366
42.
43.

Interaction of clozapine and other antipsychotic drugs with human alpha 1-adrenergic receptor subtypes.

Brooks KM, Cai J, Sandrasagra A, Roehr JE, Errazo R, Vargas HM.

Proc West Pharmacol Soc. 1999;42:67-9. No abstract available.

PMID:
10697693
44.

A clinical trial to selectively change dietary fat and/or energy intake in women: the Women's Diet Study.

Djuric Z, Uhley VE, Depper JB, Brooks KM, Lababidi S, Heilbrun LK.

Nutr Cancer. 1999;34(1):27-35.

PMID:
10453438
45.

Progesterone receptor variants found in breast cells repress transcription by wild-type receptors.

Richer JK, Lange CA, Wierman AM, Brooks KM, Tung L, Takimoto GS, Horwitz KB.

Breast Cancer Res Treat. 1998 Apr;48(3):231-41.

PMID:
9598870
46.

alpha-Adrenergic activity and cardiovascular effects of besipirdine HCl (HP 749) and metabolite P7480 in vitro and in the conscious rat and dog.

Hubbard JW, Nordstrom ST, Smith CP, Brooks KM, Laws-Ricker L, Zhou L, Vargas HM.

J Pharmacol Exp Ther. 1997 Apr;281(1):337-46.

PMID:
9103515
47.

Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.

Smith CP, Bores GM, Petko W, Li M, Selk DE, Rush DK, Camacho F, Winslow JT, Fishkin R, Cunningham DM, Brooks KM, Roehr J, Hartman HB, Davis L, Vargas HM.

J Pharmacol Exp Ther. 1997 Feb;280(2):710-20.

PMID:
9023283
48.

Food problems: soviet agriculture.

Brooks KM.

Science. 1988 Apr 22;240(4851):547-8. No abstract available.

PMID:
17784073
49.

EGF-dependent phosphorylation of the EGF receptor in plasma membranes isolated from young and senescent WI-38 cells.

Brooks KM, Phillips PD, Carlin CR, Knowles BB, Cristofalo VJ.

J Cell Physiol. 1987 Dec;133(3):523-31.

PMID:
3320064
50.

SPECT imaging of para-axial neurofibromatosis with technetium-99m DTPA.

Mandell GA, Harcke HT, Sharkey C, Brooks KM, MacEwen GD.

J Nucl Med. 1987 Nov;28(11):1688-94.

Supplemental Content

Loading ...
Support Center